Amena Mohiuddin
Hematology & Oncology · Robbinsville, NJNPI 1144726308
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in NJ, where the typical reported total is $2,686.
Across 39 payments — averaging $25.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$132
- Beone Medicines USA, Inc.$59
- Johnson & Johnson$57
- Sumitomo Pharma America, Inc.$56
- Bayer$50
- Taiho Oncology, Inc.$48
- plus $587 from 22 others
What the payments were for
- Food & beverage$97398%
- Education$152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $132 |
| Beone Medicines USA, Inc. | 3 | $59 |
| Johnson & Johnson(2 entities) | 2 | $57 |
| Sumitomo Pharma America, Inc. | 2 | $56 |
| Bayer | 2 | $50 |
| Taiho Oncology, Inc. | 2 | $48 |
| Sanofi | 2 | $48 |
| Caris MPI, Inc. | 1 | $45 |
| Novartis | 2 | $42 |
| AstraZeneca | 2 | $41 |
| Puma Biotechnology, Inc. | 2 | $41 |
| Myriad Genetic Laboratories, Inc. | 1 | $38 |
| AbbVie | 2 | $30 |
| Novocure Inc. | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Genmab U.S., Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Pfizer | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$132
How this compares
$989 in reported general payments places this provider in the 35th percentile of 362 hematology & oncology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 61 | $559 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Robbinsville
- Robert SpiegelWestfield$864K
- Amit PatelJersey City$770K
- Joshua StraussSpringfield$739K
- Charles FarberMorristown$609K
- Michael ScolaMorristown$506K
- Eshan PatelSomerville$420K
- Arturo Loaiza-BonillaPennington$406K
- Ashish ShahSpringfield$394K
- Carl HenningsonManasquan$349K
- Anthony BottiLivingston$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.